Generic Name: Ipilimumab for Melanoma, Metastatic ()
Ipilimumab for Melanoma, Metastatic Reviews
Yervoy (ipilimumab) "Two treatments in combination with OPDIVO, after the first treatment contracted sepsis, close to death but survived, after the second treatment (months apart), contracted colitis, a lot closer to death, told I had 2 days to live - spent 2 weeks in ICU. Six months later, regaining muscle, feeling stronger, cancer still in situ, but hopefully not life-threatening anymore, waiting on the latest PET/CT scans. Possibly keeping me alive, but it takes a toll on your body."
More about ipilimumab
- Check interactions
- Compare alternatives
- Reviews (4)
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-CTLA-4 monoclonal antibodies
- Breastfeeding
- En español
Patient resources
- Ipilimumab drug information
Other brands
Yervoy
Professional resources
- Ipilimumab monograph
Other brands
Yervoy
Related treatment guides
- Melanoma
- Melanoma, Metastatic
- Renal Cell Carcinoma
- Colorectal Cancer
- Malignant Pleural Mesothelioma
